X-107840687-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001382751.1(MID2):c.-39G>A variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,207,173 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 24)
Exomes 𝑓: 0.000020 ( 0 hom. 12 hem. )
Consequence
MID2
NM_001382751.1 5_prime_UTR_premature_start_codon_gain
NM_001382751.1 5_prime_UTR_premature_start_codon_gain
Scores
3
14
Clinical Significance
Conservation
PhyloP100: 1.10
Genes affected
MID2 (HGNC:7096): (midline 2) The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to microtubular structures in the cytoplasm. Alternate splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.061476678).
BS2
High Hemizygotes in GnomAdExome4 at 12 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MID2 | NM_012216.4 | c.22G>A | p.Val8Met | missense_variant | 2/10 | ENST00000262843.11 | NP_036348.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MID2 | ENST00000262843.11 | c.22G>A | p.Val8Met | missense_variant | 2/10 | 1 | NM_012216.4 | ENSP00000262843.6 | ||
MID2 | ENST00000443968.2 | c.22G>A | p.Val8Met | missense_variant | 2/10 | 1 | ENSP00000413976.2 | |||
MID2 | ENST00000451923.1 | c.-39G>A | 5_prime_UTR_premature_start_codon_gain_variant | 2/2 | 3 | ENSP00000410730.1 | ||||
MID2 | ENST00000451923.1 | c.-39G>A | 5_prime_UTR_variant | 2/2 | 3 | ENSP00000410730.1 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111731Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 33901
GnomAD3 genomes
AF:
AC:
2
AN:
111731
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
33901
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000275 AC: 5AN: 181538Hom.: 0 AF XY: 0.0000452 AC XY: 3AN XY: 66328
GnomAD3 exomes
AF:
AC:
5
AN:
181538
Hom.:
AF XY:
AC XY:
3
AN XY:
66328
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000201 AC: 22AN: 1095442Hom.: 0 Cov.: 30 AF XY: 0.0000332 AC XY: 12AN XY: 360958
GnomAD4 exome
AF:
AC:
22
AN:
1095442
Hom.:
Cov.:
30
AF XY:
AC XY:
12
AN XY:
360958
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111731Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 33901
GnomAD4 genome
AF:
AC:
2
AN:
111731
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
33901
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 20, 2024 | The c.22G>A (p.V8M) alteration is located in exon 2 (coding exon 2) of the MID2 gene. This alteration results from a G to A substitution at nucleotide position 22, causing the valine (V) at amino acid position 8 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MutPred
Gain of disorder (P = 0.023);Gain of disorder (P = 0.023);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at